Poliovirus pp 239-249 | Cite as

Generation of Infectious Poliovirus with Altered Genetic Information from Cloned cDNA

  • Erika BujakiEmail author
Part of the Methods in Molecular Biology book series (MIMB, volume 1387)


The effect of specific genetic alterations on virus biology and phenotype can be studied by a great number of available assays. The following method describes the basic protocol to generate infectious poliovirus with altered genetic information from cloned cDNA in cultured cells.

The example explained here involves generation of a recombinant poliovirus genome by simply replacing a portion of the 5′ noncoding region with a synthetic gene by restriction cloning. The vector containing the full length poliovirus genome and the insert DNA with the known mutation(s) are cleaved for directional cloning, then ligated and transformed into competent bacteria. The recombinant plasmid DNA is then propagated in bacteria and transcribed to RNA in vitro before RNA transfection of cultured cells is performed. Finally, viral particles are recovered from the cell culture.

Key words

Recombinant poliovirus cDNA cloning Restriction cloning Bacterial transformation In vitro transcription RNA transfection Virus recovery 


  1. 1.
    Racaniello VR, Baltimore D (1981) Cloned poliovirus complementary DNA is infectious in mammalian cells. Science 214:916–919CrossRefPubMedGoogle Scholar
  2. 2.
    Burrill CP et al (2013) Poliovirus: generation and characterisation of mutants. Curr Protoc Microbiol. Chapter 15:Unit 15H.2
  3. 3.
    Macadam AJ et al (2006) Rational design of genetically stable, live-attenuated poliovirus vaccines of all three serotypes: relevance to poliomyelitis eradication. J Virol 80:8653–8663CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Van der Werf S et al (1986) Synthesis of infectious poliovirus RNA by purified T7 polymerase. Proc Natl Acad Sci U S A 83:2330–2334CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Herold J, Andino R (2000) Poliovirus requires a precise 5′ end for efficient positive-strand RNA synthesis. J Virol 74:6394–6400CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  1. 1.National Institute for Biological Standards and ControlMedicines and Healthcare Products Regulatory AgencyPotters BarUK

Personalised recommendations